Home LiteratureArticle Details
PMID: 8230455 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Identification of the activation domain of equine infectious anemia virus rev.

Journal of virology ·Vol. 67 ·No. 12 ·1993-12-00 ·Pages 7317-23

Fridell RA, Partin KM, Carpenter S, Cullen BR

Abstract

Several members of the lentivirus family of complex retroviruses have been shown to encode proteins that are functionally equivalent to the Rev posttranscriptional regulatory protein of human immunodeficiency virus type 1 (HIV-1). Furthermore, the domain organization of HIV-1 Rev, featuring a highly basic N-terminal RNA binding domain and a leucin-rich C-terminal effector domain, has also been shown to be highly conserved among Rev proteins derived from not only the primate but also the ovine and caprine lentiviruses. Although it has therefore appeared highly probable that the lentivirus equine infectious anemia virus (EIAV) also encodes a Rev, the predicted amino acid sequence of this putative EIAV regulatory protein does not display any evident homology to the basic and leucine-rich motifs characteristic of other known Rev proteins. By fusion of different segments of the proposed EIAV Rev protein to the well-defined RNA binding domain of either HIV-1 or visna virus Rev, we have identified a segment of this EIAV protein that can efficiently substitute in cis for the otherwise essential activation motif. Interestingly, the minimal EIAV Rev activation motif identified in this study comprises approximately 18 amino acids located toward the protein N terminus that lack any evident similarity to the leucine-rich activation domains found in these other lentivirus Rev proteins. It therefore appears that the Rev protein of EIAV, while analogous in function to Rev proteins defined in lentiviruses of primate, ovine, and caprine origin, is nevertheless distinguished by an entirely novel domain organization.

MeSH Terms
Amino Acid Sequence Animals Cell Line Cloning, Molecular Gene Expression Regulation, Viral Genes, rev HIV-1/genetics Infectious Anemia Virus, Equine/genetics Molecular Sequence Data Open Reading Frames/genetics Recombinant Fusion Proteins Regulatory Sequences, Nucleic Acid Visna-maedi virus/genetics
Chemicals
Recombinant Fusion Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Fridell R A
Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
Partin K M
Carpenter S
Cullen B R
References (40)
40 references, click to expand
  1. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus.
    Virology. 1986 Dec;155(2):309-21 PMID: 2431539
  2. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  3. Use of eukaryotic expression technology in the functional analysis of cloned genes.
    Methods Enzymol. 1987;152:684-704 PMID: 3657593
  4. Characterization of a cDNA clone encoding the visna virus transactivating protein.
    Proc Natl Acad Sci U S A. 1989 Jan;86(2):414-8 PMID: 2536163
  5. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
  6. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  7. Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.
    Cell. 1989 Jul 14;58(1):205-14 PMID: 2752419
  8. Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein.
    Biochem Biophys Res Commun. 1989 Aug 15;162(3):963-70 PMID: 2788417
  9. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8222-6 PMID: 2682638
  10. Regulation by HIV Rev depends upon recognition of splice sites.
    Cell. 1989 Dec 1;59(5):789-95 PMID: 2686839
  11. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.
    J Virol. 1990 Jan;64(1):86-95 PMID: 2152836
  12. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
    Cell. 1990 Feb 23;60(4):675-83 PMID: 2406030
  13. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.
    J Virol. 1990 Apr;64(4):1616-24 PMID: 2157047
  14. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    J Virol. 1990 Aug;64(8):3716-25 PMID: 2164593
  15. Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.
    J Virol. 1990 Sep;64(9):4428-37 PMID: 2200888
  16. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype.
    Virology. 1990 Sep;178(1):327-30 PMID: 2202148
  17. Visna virus encodes a post-transcriptional regulator of viral structural gene expression.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7497-501 PMID: 2170981
  18. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7598-602 PMID: 2217190
  19. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 PMID: 2217212
  20. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
    Genes Dev. 1990 Aug;4(8):1357-64 PMID: 2227413
  21. Structural and functional analysis of the human immunodeficiency virus type 2 Rev protein.
    J Virol. 1991 Jan;65(1):445-9 PMID: 1985207
  22. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.
    J Virol. 1991 Mar;65(3):1605-10 PMID: 1847479
  23. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.
    Cell. 1991 Apr 19;65(2):241-8 PMID: 2015625
  24. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.
    J Virol. 1991 Jul;65(7):3460-7 PMID: 1645777
  25. Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins.
    J Virol. 1991 Jul;65(7):3877-81 PMID: 1645796
  26. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
    J Virol. 1991 Aug;65(8):4248-54 PMID: 2072452
  27. Identification of feline immunodeficiency virus rev gene activity.
    J Virol. 1991 Aug;65(8):4539-42 PMID: 1649349
  28. rev-like transcripts of caprine arthritis encephalitis virus.
    Virology. 1991 Aug;183(2):786-92 PMID: 1649509
  29. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7734-8 PMID: 1715576
  30. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.
    Cell. 1991 Oct 4;67(1):169-78 PMID: 1913815
  31. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif.
    J Virol. 1991 Nov;65(11):6001-7 PMID: 1920623
  32. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex.
    J Virol. 1991 Dec;65(12):7051-5 PMID: 1942257
  33. Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange.
    J Virol. 1992 Apr;66(4):2583-7 PMID: 1548784
  34. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.
    Biotechniques. 1991 Dec;11(6):739-40, 742-3 PMID: 1809326
  35. Structural and functional analysis of the visna virus Rev-response element.
    J Virol. 1992 Jun;66(6):3609-15 PMID: 1316470
  36. Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2.
    J Virol. 1992 Jul;66(7):4288-94 PMID: 1602545
  37. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.
    J Virol. 1992 Sep;66(9):5464-71 PMID: 1323707
  38. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.
    J Virol. 1993 Mar;67(3):1433-40 PMID: 8382305
  39. A second post-transcriptional trans-activator gene required for HTLV-III replication.
    Nature. 1986 May 22-28;321(6068):412-7 PMID: 3012355
  40. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA.
    Virology. 1987 Jun;158(2):300-12 PMID: 3035786
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-12-00
Pages
7317-23
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC238195
Subset
IM
Grants
NIAID NIH HHS · AI-28233 · United States
NIAID NIH HHS · AI-30025 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com